Inflammation in the genesis and perpetuation of atrial fibrillation.
about
The Predictive Role of Inflammatory Biomarkers in Atrial Fibrillation as Seen through Neutrophil-Lymphocyte Ratio MirrorIncreased atrial arrhythmia susceptibility induced by intense endurance exercise in mice requires TNFαLone atrial fibrillation: where are we now?Association between CHADS2 score and the preventive effect of statin therapy on new-onset atrial fibrillation in patients with acute myocardial infarction.Lone atrial fibrillation: does it exist?Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS2/CHA2DS2VASc Score.Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study.Risk of cardiovascular disorders in psoriasis patients: current and future.Response of high-sensitive C-reactive protein to catheter ablation of atrial fibrillation and its relation with rhythm outcome.Transient post-operative atrial fibrillation predicts short and long term adverse events following CABG.Effect of renal sympathetic denervation on atrial substrate remodeling in ambulatory canines with prolonged atrial pacingThe favourable effect of Helicobacter pylori eradication therapy in patients with recurrent angina-like chest pain and non-responsive to proton pump inhibitors - a preliminary study.Inflammatory markers in paroxysmal atrial fibrillation and the protective role of renin-angiotensin-aldosterone system inhibitors.High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial.Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study.Upstream therapeutic strategies of Valsartan and Fluvastatin on Hypertensive patients with non-permanent Atrial Fibrillation (VF-HT-AF): study protocol for a randomized controlled trial.Liver cirrhosis prevents atrial fibrillation: A reality or just an illusion?Oral ascorbic acid in combination with beta-blockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting.Risk of Atrial Fibrillation or Flutter Associated with Periodontitis: A Nationwide, Population-Based, Cohort Study.Is atrial fibrillation an inflammatory disorder?Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence.Hypoadiponectinemia in patients with paroxysmal atrial fibrillationRelation of hs-CRP and BNP levels with the atrial spontaneous echo contrast and thrombi in permanent atrial fibrillation patients with different etiologies.C-Reactive Protein Gene Polymorphisms and the Risk of Atrial Fibrillation in a Chinese Population in Taiwan.Hypertension and cardiac arrhythmias: a review of the epidemiology, pathophysiology and clinical implications.C-Reactive Protein and The Risk of Atrial Fibrillation: A Systematic Review and Meta-AnalysisPleiotropic effects of statins in atrial fibrillation patients: the evidence.Atrial fibrillation and renin-angiotensin system.Involvement of Src tyrosine kinase and protein kinase C in the expression of macrophage migration inhibitory factor induced by H2O2 in HL-1 mouse cardiac muscle cells.The risk of atrial fibrillation in patients with rheumatoid arthritisAtrial fibrillation: challenges and opportunities.Prediction of Atrial Fibrillation by B-type Natriuretic Peptide.Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the management of atrial fibrillation.Effect of Oral Anticoagulant Therapy on Coagulation Activity and Inflammatory Markers in Patients with Atrial Fibrillation Undergoing Ablation: A Randomized Comparison between Dabigatran and Warfarin.Value of high-sensitivity C-reactive protein assays in predicting atrial fibrillation recurrence: a systematic review and meta-analysis.Significant Increase in C-Reactive Protein and Serum Amyloid A in the Early Hours of Paroxysmal Atrial Fibrillation.Adjuvant therapy for atrial fibrillation.The Relationship Between Serum Bilirubin Concentration and Atrial FibrillationTargeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.YKL-40: a new biomarker in cardiovascular disease?
P2860
Q26742118-09128935-52C4-44D7-843C-86614BF063F3Q28394798-45305100-6868-4A4E-9866-E39B2C2F7537Q30409016-A9F50A8E-CFAB-45E2-AC0F-C4E528169058Q31134080-CE1463C5-2513-45E8-B691-057404A8407DQ33560948-4EE27FC4-DAFE-4653-93C1-F90472FD262FQ33984012-224BE996-7172-4A4C-9D42-D0990DF4C525Q34026991-BA5B8274-CF40-48B8-8528-7BFEC5C6723DQ34323212-E0149BDC-E39A-4D94-AD7D-D06865EDCDFAQ34407849-F6881C79-29E1-4048-B673-EC44AD166F03Q34457821-117F663F-A471-4CC9-B846-A9134DFDE9FCQ34749676-1054A944-2751-44C5-B80C-A6FBB9CD678AQ35673956-836F7C5B-3606-4ECE-8D3C-CDF71CD03078Q35714328-F427B8AD-3C15-47FC-BD84-A22FFBE0576DQ35756480-896002A0-C099-449F-9525-872FC1E7A342Q35815364-E50B59BB-DC33-4B3F-8F97-462DF30EF180Q35926637-76264600-30CF-4B79-B221-C9628CB46CC1Q35966609-A3B1B8B7-96F9-43C7-BD1E-15289CCFA018Q36015478-65E7EF16-054F-425C-8163-B440F81E18A0Q36178661-29C47871-6BA4-4AD4-AB68-7A0475682A8BQ36309624-297B62F4-4289-4150-859B-86C95F42D141Q36324110-A97D65A1-1518-4326-BFAF-29489FB9C58DQ36385440-B041B1BD-3135-44D8-A66F-0B6EDE198C64Q36576860-E01A8B25-468E-4C67-B1CB-7880B657B00BQ36721318-B3676B03-12A7-48F3-9CA0-6A127139A4A1Q37109220-37F03C2F-5F9A-4754-AB6C-75FA1C3D80C9Q37115344-54F6AD90-BF6D-473F-BC4A-D5C85D678A5BQ37248230-4A43303F-10EE-459F-8FFD-1C755917C6D4Q37362745-A5B6B2CA-1DEF-498C-AA86-10D3604EB777Q37371544-82236E80-CAC0-429B-9E07-E91F4780297FQ37446317-308CC271-F680-400B-9134-03F299EDAA4EQ37476763-E76DC249-DE63-4431-BBB2-4527E18B295AQ37496146-3B405C49-2244-422D-83DA-0706587388E0Q37506170-E811C887-92A1-4389-A332-3CE448D6C9B7Q37576987-80BCC83F-E3E7-4B40-91BA-5079619A9A8AQ37598033-6015349A-A597-47A6-8AD1-F3BB8A0DDD4EQ37629202-924B4018-27FA-42A1-BD3D-68B3CB2C7929Q37656338-9A8133D2-51CF-467E-A0B4-7D2336769F51Q37711525-AC1F576F-DBE8-4569-A29F-9D6E9D48B431Q37734257-67615968-2457-497E-B17F-BED843C04E71Q37779310-AFCB3D96-5002-4689-9280-4410FDCB0CE7
P2860
Inflammation in the genesis and perpetuation of atrial fibrillation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Inflammation in the genesis and perpetuation of atrial fibrillation.
@ast
Inflammation in the genesis and perpetuation of atrial fibrillation.
@en
type
label
Inflammation in the genesis and perpetuation of atrial fibrillation.
@ast
Inflammation in the genesis and perpetuation of atrial fibrillation.
@en
prefLabel
Inflammation in the genesis and perpetuation of atrial fibrillation.
@ast
Inflammation in the genesis and perpetuation of atrial fibrillation.
@en
P356
P1476
Inflammation in the genesis and perpetuation of atrial fibrillation.
@en
P2093
Mads D M Engelmann
P304
P356
10.1093/EURHEARTJ/EHI350
P577
2005-06-23T00:00:00Z